Accuracy of pre‐operative 18‐fluoride fluorodeoxyglucose positron emission tomography ( FDG‐PET ) in predicting lymph node involvement in colon cancer
ANZ Journal of Surgery · 2023
DOI: 10.1111/ans.18637 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2023. Verfasst von Chahaya Marc Gauci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department Colorectal Surgery, St George Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Colonic Neoplasms, Lymphadenopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Accurate staging of colon cancer is imperative in directing treatment and prognostication. Existing literature on pre‐operative accuracy of FDG‐PET/CT in detecting lymph node disease often combines colon and rectal cancer, examines rectal cancers alone, and rarely assesses colon cancer in isolation. Our aim was to assess pre‐operative utility of FDG‐PET/CT in detecting lymph node disease in colon cancer.
Methods
A retrospective cohort analysis was performed at a single Australian institution between 2017 and 2022 to identify treatment naive primary colonic tumours. Primary outcome was sensitivity and specificity using formal surgical histopathology as gold standard. Secondary outcomes were patient and tumour factors predictive of FDG‐PET/CT positive disease including pre‐operative CEA, mismatch repair status, duration to surgery, and tumour T‐stage.
Results
Three hundred and thirty‐nine patients were identified. Thirty‐four had pre‐operative FDG‐PET/CT without neoadjuvant therapy. The mean surgical lymph node harvest was 18 nodes. Twenty‐five patients had moderately differentiated tumours. The median duration between FDG‐PET/CT and operation was 17 days. Pre‐operative FDG‐PET/CT suggested positive lymph node involvement in 12 patients. Compared to final lymph node histopathology, FDG‐PET/CT had a sensitivity of 53%, specificity of 82%, positive predictive value of 75%, negative predictive value of 64% and accuracy of 68%. There was no significant difference between groups for secondary outcomes.
Conclusion
FDG‐PET/CT has moderate specificity but poor sensitivity in the detection of lymph node involvement in colon cancer. Its utility should likely remain isolated to investigating equivocal lesions or follow up of known PET avid disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Colorectal Surgery, St George Hospital, Sydney, New South Wales, Australia.
- St George & Sutherland Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
- Liverpool Hospital Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
ORCID-Profile: Chahaya Marc Gauci, Tae Jun Kim
Zitieren
APA
Gauci, C. M., Kim, T. J., Gao, Y., & Perera, D. S. (2023). Accuracy of pre‐operative 18‐fluoride fluorodeoxyglucose positron emission tomography ( FDG‐PET ) in predicting lymph node involvement in colon cancer. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18637
Vancouver
Gauci CM, Kim TJ, Gao Y, Perera DS. Accuracy of pre‐operative 18‐fluoride fluorodeoxyglucose positron emission tomography ( FDG‐PET ) in predicting lymph node involvement in colon cancer. ANZ Journal of Surgery. 2023. doi:10.1111/ans.18637
BibTeX
@article{Gauci2023,
author = {Gauci, Chahaya Marc and Kim, Tae Jun and Gao, Yijun and Perera, Dayashan S},
title = {Accuracy of pre‐operative 18‐fluoride fluorodeoxyglucose positron emission tomography ( FDG‐PET ) in predicting lymph node involvement in colon cancer},
journal = {ANZ Journal of Surgery},
year = {2023},
doi = {10.1111/ans.18637}
}
EUVIMED